NCT01427010View on ClinicalTrials.gov

A Feasibility Study on Adaptive 18F-FDG-guided Radiotherapy for Recurrent and Second Primary Head and Neck Cancer in the Previously Irradiated Territory.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2015

Conditions

Re-irradiation in Recurrent and Second Primary Head and Neck Cancer

Interventions

RADIATION

[18F]FDG-PET-voxel intensity-based IMRT

Non-controlled, non-randomized, prospective study on 18F-Fluorodeoxyglucose-Positron Emission Tomography (\[18F\]FDG-PET)-voxel intensity-based intensity-modulated radiotherapy (IMRT) (dose painting) adapted to the anatomical and biological changes as detected by per-treatment FDG-PET/Computertomography (CT) acquired at the end of the 2nd and the 4th week of treatment.

Trial Locations (2)

9000

University Hospital Ghent, Ghent

Unknown

Antwerp University Hospital, Antwerp

All Listed Sponsors

lead

University Hospital, Ghent

OTHER

NCT01427010 - A Feasibility Study on Adaptive 18F-FDG-guided Radiotherapy for Recurrent and Second Primary Head and Neck Cancer in the Previously Irradiated Territory. | Biotech Hunter | Biotech Hunter